(-)-Epicatechin and the comorbidities of obesity

Archives of Biochemistry and Biophysics
Eleonora CremoniniPatricia I Oteiza

Abstract

Obesity has major adverse consequences on human health contributing to the development of, among others, insulin resistance and type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, altered behavior and cognition, and cancer. Changes in dietary habits and lifestyle could contribute to mitigate the development and/or progression of these pathologies. This review will discuss current evidence on the beneficial actions of the flavan-3-ol (-)-epicatechin (EC) on obesity-associated comorbidities. These benefits can be in part explained through EC's capacity to mitigate several common events underlying the development of these pathologies, including: i) high circulating levels of glucose, lipids and endotoxins; ii) chronic systemic inflammation; iii) tissue endoplasmic reticulum and oxidative stress; iv) insulin resistance; v) mitochondria dysfunction and vi) dysbiosis. The currently known underlying mechanisms and cellular targets of EC's beneficial effects are discussed. While, there is limited evidence from human studies supplementing with pure EC, other studies involving cocoa supplementation in humans, pure EC in rodents and in vitro studies, support a potential beneficial action of EC on obesity-associated...Continue Reading

References

Jun 29, 2000·The American Journal of Clinical Nutrition·D ReinC L Keen
Jun 7, 2003·The American Journal of Clinical Nutrition·Karen J MurphyAndrew J Sinclair
Aug 28, 2003·JAMA : the Journal of the American Medical Association·Christian HeissMalte Kelm
Oct 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Fredrik BäckhedJeffrey I Gordon
Jan 11, 2005·The American Journal of Clinical Nutrition·Carl L KeenHarold H Schmitz
Jan 11, 2005·The American Journal of Clinical Nutrition·Helmut SiesMalte Kelm
Feb 17, 2005·Clinical & Developmental Immunology·Cesar G FragaCarl L Keen
Mar 11, 2005·FEBS Letters·Kelly JohnstonLinda Morgan
Jan 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hagen SchroeterMalte Kelm
Mar 10, 2006·Journal of Cell Science·Peter J Espenshade
Jun 24, 2006·Journal of Cardiovascular Pharmacology·Roberta R HoltCarl L Keen
Jun 28, 2006·Eating and Weight Disorders : EWD·J GunstadE Gordon
Oct 4, 2006·Free Radical Biology & Medicine·Alejandra G ErlejmanPatricia I Oteiza
Dec 21, 2006·Journal of Agricultural and Food Chemistry·James M HarnlySusan Gebhardt
Apr 26, 2007·Diabetes·Patrice D CaniRémy Burcelin
Jun 1, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Henriette van PraagFred H Gage
Nov 6, 2007·The British Journal of Nutrition·Xenofon TzounisJeremy P E Spencer
Nov 13, 2007·Archives of Biochemistry and Biophysics·Yvonne SteffenHelmut Sies
Apr 3, 2008·Mayo Clinic Proceedings·John K DiBaiseBruce E Rittmann
May 28, 2008·International Journal of Obesity : Journal of the International Association for the Study of Obesity·K DavisonP R C Howe
Oct 29, 2008·Seminars in Liver Disease·Mariana Lazo, Jeanne M Clark
Dec 17, 2008·The American Journal of Clinical Nutrition·Séverine SabiaArchana Singh-Manoux
Jul 21, 2009·Free Radical Biology & Medicine·Manuela AragnoGiuseppe Boccuzzi
Oct 2, 2009·Journal of Clinical Biochemistry and Nutrition·Naomi Osakabe, Megumi Yamagishi
Dec 17, 2009·Journal of Neuroimmunology·Paul J PistellAnnadora J Bruce-Keller
Apr 15, 2010·Archives of Biochemistry and Biophysics·Mónica GalleanoCesar G Fraga
Jul 8, 2010·Dementia and Geriatric Cognitive Disorders·Linda B HassingBoo Johansson
Sep 8, 2010·The Journal of Biological Chemistry·Bhaskar PonugotiJongsook Kim Kemper
Sep 30, 2010·Current Pharmaceutical Biotechnology·Monica GalleanoCesar G Fraga
Oct 26, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·D D MellorS L Atkin
Feb 8, 2011·Journal of Clinical Biochemistry and Nutrition·César G FragaMónica Galleano
Apr 19, 2011·Journal of Agricultural and Food Chemistry·Yeyi GuJoshua D Lambert
May 12, 2011·European Journal of Clinical Nutrition·O A TokedeL Djoussé

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Related Papers

Archives of Biochemistry and Biophysics
Eleonora CremoniniPatricia I Oteiza
The International Journal of Biochemistry & Cell Biology
Ahmed BettaiebPatricia I Oteiza
Critical Reviews in Food Science and Nutrition
Zhihao QuSheng Zhang
© 2021 Meta ULC. All rights reserved